Results 11 to 20 of about 315,545 (404)
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice [PDF]
The FDA approved drug rapamycin increases lifespan in rodents and delays age-related dysfunction in rodents and humans. Nevertheless, important questions remain regarding the optimal dose, duration, and mechanisms of action in the context of healthy ...
Anderson +33 more
core +2 more sources
Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective
Large language models utilizing transformer neural networks and other deep learning architectures demonstrated unprecedented results in many tasks previously accessible only to human intelligence. In this article, we collaborate with ChatGPT, an AI model
A. Zhavoronkov
semanticscholar +1 more source
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Novel targets to arrest neurodegeneration in several dementing conditions involving misfolded protein accumulations may be found in the diverse signaling pathways of the Mammalian/mechanistic target of rapamycin (mTOR).
H. Querfurth, Han-Kyu Lee
semanticscholar +1 more source
Evaluation of off-label rapamycin use to promote healthspan in 333 adults
Rapamycin (sirolimus) is an FDA-approved drug with immune-modulating and growth-inhibitory properties. Preclinical studies have shown that rapamycin extends lifespan and healthspan metrics in yeast, invertebrates, and rodents.
T. Kaeberlein +12 more
semanticscholar +1 more source
The licensed drug rapamycin has potential to be repurposed for geroprotection. A key challenge is to avoid adverse side effects from continuous dosing. Here we show that geroprotective effects of chronic rapamycin treatment can be obtained with a brief ...
Paula Juricic +12 more
semanticscholar +1 more source
Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle
Preserving skeletal muscle function is essential to maintain life quality at high age. Calorie restriction (CR) potently extends health and lifespan, but is largely unachievable in humans, making “CR mimetics” of great interest.
D. J. Ham +15 more
semanticscholar +1 more source
Combining reverse end-to-side neurorrhaphy with rapamycin treatment on chronically denervated muscle in rats [PDF]
This preliminary research determines whether a combination of reverse end-to-side neurorrhaphy and rapamycin treatment achieves a better functional outcome than a single application after prolonged peripheral nerve injury.
Yijian Chen +6 more
doaj +1 more source
Effect of rapamycin on aging and age-related diseases—past and future
In 2009, rapamycin was reported to increase the lifespan of mice when implemented later in life. This observation resulted in a sea-change in how researchers viewed aging.
R. Selvarani +2 more
semanticscholar +1 more source
Trauma to the knee joint is associated with significant cartilage degeneration and erosion of subchondral bone, which eventually leads to osteoarthritis (OA), resulting in substantial morbidity and healthcare burden.
Kaamini M. Dhanabalan +5 more
doaj +1 more source
Rapamycin induces transactivation of the EGFR and increases cell survival. [PDF]
The mammalian target of rapamycin (mTOR) signaling network regulates cell growth, proliferation and cell survival. Deregulated activation of this pathway is a common event in diverse human diseases such as cancers, cardiac hypertrophy, vascular ...
Chaturvedi, D +4 more
core +2 more sources

